Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0XS3W
|
|||
| Former ID |
DNC006885
|
|||
| Drug Name |
1-adamantan-1-yl-3-(1-ethyl-piperidin-4-yl)-urea
|
|||
| Synonyms |
CHEMBL214534; 1-adamantan-1-yl-3-(1-ethyl-piperidin-4-yl)-urea; SCHEMBL5146577
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C18H31N3O
|
|||
| Canonical SMILES |
CCN1CCC(CC1)NC(=O)NC23CC4CC(C2)CC(C4)C3
|
|||
| InChI |
1S/C18H31N3O/c1-2-21-5-3-16(4-6-21)19-17(22)20-18-10-13-7-14(11-18)9-15(8-13)12-18/h13-16H,2-12H2,1H3,(H2,19,20,22)
|
|||
| InChIKey |
SMBXAXBAAIGIAK-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Soluble epoxide hydrolase (EPHX2) | Target Info | Inhibitor | [1] |
| KEGG Pathway | Arachidonic acid metabolism | |||
| Metabolic pathways | ||||
| Peroxisome | ||||
| Pathwhiz Pathway | Arachidonic Acid Metabolism | |||
| WikiPathways | Metapathway biotransformation | |||
| Arachidonate Epoxygenase / Epoxide Hydrolase | ||||
| Arachidonic acid metabolism | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Synthesis and SAR of conformationally restricted inhibitors of soluble epoxide hydrolase. Bioorg Med Chem Lett. 2006 Oct 1;16(19):5212-6. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.